Clinical Trials Directory

Trials / Conditions / Esophagogastric Junction Cancer

Esophagogastric Junction Cancer

12 registered clinical trials studyying Esophagogastric Junction Cancer4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingNeoadjuvant Cadonilimab Plus Chemotherapy for Locally Advanced Esophagogastric Junction and Gastric Cancer Tri
NCT06310473
Nanfang Hospital, Southern Medical UniversityPhase 2
WithdrawnChemoRadiation And Tislelizumab for Esophageal/EGJ Cancer
NCT05245760
Zhonglin HaoPhase 2
UnknownClinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastr
NCT05275062
Beijing Immunochina Medical Science & Technology Co., Ltd.EARLY_Phase 1
CompletedGlycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)
NCT05259696
Palleon Pharmaceuticals, Inc.Phase 1 / Phase 2
TerminatedADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-
NCT04752358
AdaptimmunePhase 2
RecruitingDevelopment of a Clinical Decision Support System With Artificial Intelligence for Cancer Care
NCT04675138
National University Hospital, Singapore
UnknownA Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Di
NCT03139487
Asan Medical CenterPhase 2
UnknownChemotherapy for Potentially Resectable Locally Advanced Esophagogastric Junction Carcinoma
NCT03211377
Anyang Tumor Hospital
CompletedPhase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esopha
NCT02979691
Chinese Academy of Medical SciencesPhase 2 / Phase 3
RecruitingMRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esoph
NCT02988921
Cancer Institute and Hospital, Chinese Academy of Medical SciencesN/A
CompletedA Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcin
NCT01248403
Krankenhaus NordwestPhase 3
RecruitingChemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
NCT04821778
Cancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 3